Hongyan Gou

Shenzhen, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 31 publications

Gut pathobionts translocate into liver and reshape intrahepatic microbiome to facilitate hepatocellular carcinoma.

Gut pathobionts translocate into liver and reshape intrahepatic microbiome to facilitate hepatocellular carcinoma.

Journal: Cancer discovery
Published: September 23, 2025

Correction: TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling.

Correction: TTPAL promotes gastric tumorigenesis by directly targeting NNMT to activate PI3K/AKT signaling.

Journal: Oncogene
Published: April 24, 2025

Stomach microbiota in gastric cancer development and clinical implications.

Stomach microbiota in gastric cancer development and clinical implications.

Journal: Gut
Published: May 07, 2024

Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer.

Gut microbial metabolites: Shaping future diagnosis and treatment against gastrointestinal cancer.

Journal: Pharmacological research
Published: May 01, 2024

A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis.

A blood-based biomarker panel for non-invasive diagnosis of metabolic dysfunction-associated steatohepatitis.

Journal: Cell metabolism
Published: February 24, 2024

TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.

TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.

Journal: Cancer letters
Published: July 20, 2023

Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.

Integrative plasma and fecal metabolomics identify functional metabolites in adenoma-colorectal cancer progression and as early diagnostic biomarkers.

Journal: Cancer cell
Published: April 12, 2023

TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target.

TMEM65 promotes gastric tumorigenesis by targeting YWHAZ to activate PI3K-Akt-mTOR pathway and is a therapeutic target.

Journal: Oncogene
Published: March 13, 2023

Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites.

Traditional Medicine Pien Tze Huang Suppresses Colorectal Tumorigenesis Through Restoring Gut Microbiota and Metabolites.

Journal: Gastroenterology
Published: October 18, 2022

Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer.

Targeting m6A reader YTHDF1 augments antitumour immunity and boosts anti-PD-1 efficacy in colorectal cancer.

Journal: Gut
Published: October 05, 2022

Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.

Targeting of SLC25A22 boosts the immunotherapeutic response in KRAS-mutant colorectal cancer.

Journal: Nature communications
Published: September 30, 2022

The N6-methyladenine DNA demethylase ALKBH1 promotes gastric carcinogenesis by disrupting NRF1 binding capacity.

The N6-methyladenine DNA demethylase ALKBH1 promotes gastric carcinogenesis by disrupting NRF1 binding capacity.

Journal: Cell reports
Published: July 26, 2022
Showing 1-12 of 31

Last Updated: 09/26/2026